Clinical Application of CAR T Cells 2017

Clinical Application of CAR T Cells 2017 Banner

Date & Location
Thursday, November 16, 2017, 8:00 AM - Friday, November 17, 2017, 5:00 PM, Zuckerman Research Center 417 E 68th St, New York, NY

Target Audience
Allergy & Immunology, Bone Marrow Transplant, Breast Medical Oncology, Hematology & Oncology, Leukemia, Lymphoma, Pediatric Oncology, Solid Tumor Oncology, Thoracic Medical Oncology


Chimeric antigen receptor (CAR) T-cell (’Living Drug’) immunotherapy is showing promising results in the treatment of cancers. There are nine ongoing clinical trials (Phase I & II) at Memorial Sloan Kettering (MSK) and more are on track to be initiated next year. Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside – choosing the ideal antigen target, constructing clinical grade CARs and vectors, investigating CARs in clinically relevant models, manufacturing, quality control, developing protocols for FDA approval, optimizing consent forms that cover emerging ethical issues, managing complications, and conducting world-class correlative science.

MSK faculty, along with national and international experts, will discuss the clinical and translational aspects of cell therapies (CARs, TCRs, NKs), both for hematologic malignancies and solid tumors. 

Participants are invited to join the course faculty for a networking reception at Rockefeller University’s Weiss Café on November 16th.

Rockefeller University
1230 York Avenue, New York, NY
5:00-7:00 pm

CALL FOR ABSTRACTS (deadline: November 10, 2017)

Participants are invited to submit an abstract for presentation at the course. Abstracts for the poster session will be selected on the basis of scientific merit and content quality. To submit an abstract for presentation, please select 'Abstracts' above. 

Main Sessions

  • CARs for B-cell Malignancies
  • Managing Toxicities
  • The Ins and Outs of Manufacturing Engineered Cells
  • CARs for Non-B-cell Hematologic Malignancies
  • Non-T-cell Therapies
  • Novel Cell-based Technologies
  • TCRs and BiTEs
  • National Guidelines for CAR T-cell Therapy Programs
  • CARs for Solid Tumors

Breakout Session Topics

  • Clinical and Operational Infrastructure of Engineered Cell Therapy
  • Novel T-cell-based Technologies and Assays

Optional Non-CME Industry Sessions

There will be two optional non-CME industry sessions for attendees, one on Thursday from 3:45pm - 5:00pm and another on Friday from 9:15am - 10:45am. Please note that Memorial Sloan Kettering Cancer Center will not be offering CME credits for the either industry session.
View the industry sessions agenda.

Target Audience

The target audience includes medical oncologists and oncology fellows in training, basic scientists, research fellows in training, nurses, clinical trial research staff, immunologists, and surgeons with an interest in tumor immunology and immunotherapy.


Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants or financial support for this live activity:

  • ACEA Biosciences, Inc.
  • Adaptive Biotechnologies 
  • Eureka Therapeutics, Inc.
  • Juno Therapeutics
  • Kite, a Gilead Company
  • Novartis

  1. To learn new developments in CAR T-cell therapy
  2. To learn patient toxicity management
  3. To learn patient clinical tiral management algorithms


Registration Fees Early*       General  
 Academia Fees      
 Physicians (MDs, PhDs and DOs)
$500 $600  
 Residents, Fellows, Nurses and Other Healthcare Providers     
 Industry Fees

 All Members (any employee working for a commercial interest**)       n/a $1,500

*Early Registration - Apply promo code CARTEARLY7 at checkout (deadline 10/30/2017)
**The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. Please click here for more information or email if you have additional questions. 

Registration Details

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact at least one week prior to the course if you have any special dietary needs.

  • 30% Discounted Rate for MSK Alumni and MSK Alliance Members 
    MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact for a promo code or more information. 
  • MSK Employee Registration Waitlist  
    MSK staff interested in registering for this course should join the waitlist. We will notify you before the course if space is available.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.


Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians

AMA Credit Designation

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that Memorial Sloan Kettering Cancer Center will not be offering CME credits for the optional non-CME industry sessions.

CME hours from this conference qualify for the Federation for the Accreditation of Cellular Therapy (FACT) Immune Effector Cells (IEC) annual training requirement (10 hrs needed).

CE Credits

This course will not offer nursing CE credits. Nurses will receive a non-physician CME certificate for AMA PRA Category 1 Credit(s)™.  Certain nursing certification providers (such as ANCC) may accept this certificate for CE requirements. Please check with your certification providers for more information.